An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect . Clinics, [S. l.], v. 66, n. 5, p. 837–841, 2011. DOI: 10.1590/S1807-59322011000500021. Disponível em: https://www.revistas.usp.br/clinics/article/view/19562.. Acesso em: 15 jun. 2024.